Evangelos Terpos

Differential donor‐, cell type‐ and drug‐specific molecular responses to therapeutic proteasome inhibitors in Multiple Myeloma patients and cells

Introduction: Purpose of the study: Proteasome over‐activation represents a hallmark of several advanced tumors and thus, its selective inhibition provides a promising anti‐tumor the...

Ourania Tsitsilonis ;

Herman Overkleeft ;

Leonidas Alexopoulos ;

Ioannis Trougakos ;

Meletios-Athanasios Dimopoulos ;

Eleni-Dimitra Papanagnou ;

Efstathios Kastritis ;

Aikaterini Skorda ;

Aimilia Sklirou ;

Evangelos Terpos ;

10/22/2019

Featured Webinar

Implementing ERAS Protocols Throughout Patient Peri-Op Journey: Reductions in Complications

Upcoming Events

November 6 ⁠–⁠ November 8

November 7 ⁠–⁠ November 10

November 8

November 8 ⁠–⁠ November 10

November 13 ⁠–⁠ November 16

November 14 ⁠–⁠ November 15

November 23 ⁠–⁠ November 24

December 4 ⁠–⁠ December 5

Great Debates & Updates in Diabetic Foot

December 6 ⁠–⁠ December 7

December 9 ⁠–⁠ December 11

See Full Calendar

Evangelos Terpos

Featured Webinar

Upcoming Events

Specialties

Events

Year Round Education

HMP Global Products